| BALFX | WBCCX | BALFX / WBCCX | |
| Total Expense Ratio | 0.61 | 2.18 | 28% |
| Annual Report Gross Expense Ratio | 0.61 | 2.18 | 28% |
| Fund Existence | 25 years | 25 years | - |
| Gain YTD | 8.372 | 4.727 | 177% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 288B | 30.8M | 935,065% |
| Annual Yield % from dividends | 1.78 | 0.23 | 785% |
| Returns for 1 year | 11.29 | -4.75 | -238% |
| Returns for 3 years | 38.49 | 1.68 | 2,293% |
| Returns for 5 years | 32.23 | -18.14 | -178% |
| Returns for 10 years | 82.24 | -13.33 | -617% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PLBEX | 34.87 | 0.45 | +1.31% |
| Plumb Equity Investor | |||
| JHACX | 10.17 | 0.01 | +0.10% |
| JHancock Multi-Asset Absolute Return C | |||
| HNIDX | 16.30 | -0.11 | -0.67% |
| Harbor Diversified Intl All Cp Retire | |||
| ERSMX | 29.37 | -0.20 | -0.68% |
| Eaton Vance Atlanta Capital SMID-Cap R | |||
| FBTIX | 49.83 | -1.21 | -2.37% |
| Fidelity Advisor Biotechnology I | |||